Imatinib vs Metformin
Imatinib vs Metformin: Overview
This comparison examines the pharmacological differences between Imatinib and Metformin.
Mechanism of Action
Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.
Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.
Pharmacokinetics
Half-life: Imatinib β 18 hours; Metformin β 4-9 hours.
Chemical Properties
Molecular Formula: Imatinib β C29H31N7O; Metformin β C4H11N5.
Molecular Weight: Imatinib β 493.6030 g/mol; Metformin β 129.1640 g/mol.
Type: Imatinib β Small molecule; Metformin β Small molecule.